| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/06/2000 | CA2345462A1 Treatment of hepatitis b infection with thymosin alpha 1 in combination with lamivudine or in combination with lamivudine and famciclovir |
| 04/06/2000 | CA2345414A1 Eyedrops for promoting lacrimal secretion or treating keratoconjunctival disorders containing natriuretic peptide as active ingredient |
| 04/06/2000 | CA2345407A1 Synthesis of cyclic peptides |
| 04/06/2000 | CA2345347A1 Methods for treating or preventing viral infections and associated diseases |
| 04/06/2000 | CA2345243A1 Inhibition of erythrocyte sickling by n-l-alpha-aspartyl-l-phenylalanine 1-methyl ester |
| 04/06/2000 | CA2345075A1 Mixed liposome drug delivery system using membrane mimetics |
| 04/06/2000 | CA2344763A1 Human carbohydrate-associated proteins |
| 04/06/2000 | CA2344714A1 Hrpca 9 and hrpca 10 nucleic acids and polypeptides |
| 04/06/2000 | CA2344712A1 Secretory protein- zsig48 |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | CA2344622A1 Moraxella catarrhalis protein, nucleic acid sequence and uses thereof |
| 04/06/2000 | CA2344604A1 Polymeric hemoglobin mutants |
| 04/06/2000 | CA2344578A1 Polistinae venom phospholipase |
| 04/06/2000 | CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 04/06/2000 | CA2344550A1 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 04/06/2000 | CA2344464A1 Dnas encoding novel polypeptides |
| 04/06/2000 | CA2344274A1 Angiotensin converting enzyme homolog and its use |
| 04/06/2000 | CA2344107A1 Atp binding cassette genes and proteins for diagnosis and treatment of lipid disorders and inflammatory diseases |
| 04/06/2000 | CA2343975A1 Ncam binding compounds |
| 04/06/2000 | CA2343965A1 Use of s-ydcb and b-ydcb, essential bacterial genes |
| 04/06/2000 | CA2343939A1 Genes and proteins predictive and therapeutic for stroke, hypertension, diabetes and obesity |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343929A1 Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use |
| 04/06/2000 | CA2343927A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | CA2343924A1 Peptide derivative |
| 04/06/2000 | CA2343716A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | CA2343696A1 Membrane-associated organizational proteins |
| 04/06/2000 | CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | CA2343335A1 Hedgehog and patched antagonists for inhibiting cell and tissue growth and differentiation and uses therefor |
| 04/06/2000 | CA2343109A1 Thrombin inhibitors |
| 04/06/2000 | CA2342310A1 Treatment of wilt diseases |
| 04/06/2000 | CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto |
| 04/06/2000 | CA2310804A1 Novel dkr polypeptides |
| 04/06/2000 | CA2285151A1 Novel heparin binding peptides |
| 04/06/2000 | CA2249675A1 A novel composition containing cyclosporin |
| 04/05/2000 | EP0990924A1 Biomedical devices with antimicrobial coatings |
| 04/05/2000 | EP0990703A1 Novel polypeptide, dna encoding the same and use thereof |
| 04/05/2000 | EP0990044A1 A method for in vitro molecular evolution of protein function |
| 04/05/2000 | EP0990042A1 Regulatory sequences involved in hypoxia regulated gene expression and uses thereof |
| 04/05/2000 | EP0990038A1 New human lysophospholipase |
| 04/05/2000 | EP0990037A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 04/05/2000 | EP0990034A1 Anti-gpiib/iiia recombinant antibodies |
| 04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
| 04/05/2000 | EP0990022A1 $i(TREPONEMA PALLIDUM) POLYNUCLEOTIDES AND SEQUENCES |
| 04/05/2000 | EP0990000A1 Connective tissue growth factor-3 |
| 04/05/2000 | EP0989999A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/05/2000 | EP0989996A2 Human preprotachykinin b |
| 04/05/2000 | EP0989995A2 Torsin, torsin genes, and methods of use |
| 04/05/2000 | EP0989994A1 Streptogramines, their preparation and compositions containing them |
| 04/05/2000 | EP0989993A1 Tartrate salt of a substituted dipeptide as growth hormone secretagogue |
| 04/05/2000 | EP0989860A1 Methods and compositions for inactivating infectious agents using lactoferrin and related molecules |
| 04/05/2000 | EP0989859A1 Cns neuroregenerative compositions and methods of use |
| 04/05/2000 | EP0989858A1 Cd28/ctla-4 inhibiting peptidomimetics, pharmaceutical compositions thereof, and method of using same |
| 04/05/2000 | EP0989857A1 Novel therapeutic agents that modulate enzymatic processes |
| 04/05/2000 | EP0989855A1 Osteoarthritis cartilage regeneration using human mesenchymal stem cells |
| 04/05/2000 | EP0989854A1 Compositions useful as fibrin sealants |
| 04/05/2000 | EP0989853A1 Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | EP0795007A4 Bioengineered human blood cells |
| 04/05/2000 | EP0794959B1 Amino acids for making betides and methods of screening and making betide libraries |
| 04/05/2000 | EP0792369B1 Suicide genes and combinations of pyrimidine nucleoside and nucleobase analogues with suicide genes for gene therapy |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0750631B1 Novel mercaptoacetylamido 1,3,4,5-tetrahydro-benzo(c)azepin-3-one disulfide derivatives useful as inhibitors of enkephalinase and ace |
| 04/05/2000 | EP0733072B1 Antibody against carcinoembryonic antigen (cea) |
| 04/05/2000 | EP0716661B1 Pseudo- and non-peptide bradykinin receptor antagonists |
| 04/05/2000 | EP0618811B1 Proteolytic mixture containing escharase and method of isolating same |
| 04/05/2000 | EP0595873B1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/05/2000 | EP0568622B1 CORTICOTROPIN RELEASING FACTOR BINDING PROTEIN (CRF-bp) |
| 04/05/2000 | EP0479866B1 Pestivirus nucleotide sequences and polypeptides, in particular from hog cholera virus |
| 04/05/2000 | CN1249781A Epitopes of protein pre-M/M of dengue virus, synthetic peptides |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249691A Immobilized activity stabilized LHRH-antagonist complexes, method for production thereof |
| 04/05/2000 | CN1249690A Treatment of multiple sclerosis through ingestion or inhalation of copolymer-1 |
| 04/05/2000 | CN1249688A Self-regulated apoptosis of inflammatory cells by gene therapy |
| 04/05/2000 | CN1249682A Use of angiotension II antagonists to treat symptomatic heart failure |
| 04/05/2000 | CN1249175A Skin-protecting cosmetics |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1051083C Novel substd. puriny derivs. with immunomodulating activity |
| 04/05/2000 | CN1051020C Method for preparing venin cream |
| 04/05/2000 | CN1050995C Elaboration of host defense mediators into biological fluids by systemic ds RNA treatment |
| 04/04/2000 | US6046340 Imidazole containing pseudodipeptide product and compositions containing the same |
| 04/04/2000 | US6046328 Combination preparation, containing cyclosporin A or FK506 or rapamycin and a xanthine derivative |
| 04/04/2000 | US6046321 Compound of 8 to 30 nucleobases targeted to nucleic acid encoding human g protein involved in hormonal inhibition of adenylyl cyclase and regulation of plasma membrane enzymes; for diagnosis, prophylaxis and treatment of related diseases |
| 04/04/2000 | US6046320 Compound 8 to 30 nucleobases in length which hybridizes a human nucleic acid which encodes an oncogene, mdm2-like p53 binding protein; for therapy or prophylaxis of related diseases |
| 04/04/2000 | US6046319 Antisense oligodeoxynucleotides regulating expression of TNF-α |
| 04/04/2000 | US6046318 Isolated cdna which encodes a protein having one or more cysteine containing domains; for diagnosis, therapy, recombinant production, and as probes to isolate related proteins in other species and organisms |
| 04/04/2000 | US6046317 For screening for carrier status and diagnosis of predisposition for increased serum cholesterol or low density lipoprotein cholesterol level in humans |
| 04/04/2000 | US6046315 Disease associated calmodulin protein |
| 04/04/2000 | US6046314 Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 04/04/2000 | US6046309 Macrophage-derived inflammatory mediator (MIP-1α and MIP-1β) |
| 04/04/2000 | US6046308 Isolated TRBP polypeptides and uses therefor |
| 04/04/2000 | US6046307 Modulation of mammalian telomerase by peptide nucleic acids |
| 04/04/2000 | US6046289 For inhibiting coagulation of blood platelets, inhibiting adhesion of animal cells, or as substrate for culturing animal cells |
| 04/04/2000 | US6046238 Method for treating or preventing the spread of acne vulgaris |
| 04/04/2000 | US6046224 12 (S)--hete receptor blockers |
| 04/04/2000 | US6046219 Administering to the patient for treating the conditions mediated by collagen formation together with cell proliferation a hydroxypyridine derivative |
| 04/04/2000 | US6046180 NAALADase inhibitors |
| 04/04/2000 | US6046174 Tryptophanyl tRNA synthetase, trpS, of Streptococcus pneumoniae |
| 04/04/2000 | US6046170 Therapeutic use of hemoglobin to treat head injury |